Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients

Transplantation Research

Volumn 2, Issue 1, 2013, Pages

  Robertsen, Ida ^a   Falck, Pål ^a   Andreassen, Arne K ^b   Næss, Nina K ^a   Lunder, Niclas ^c   Christensen, Hege ^a   Gullestad, Lars ^b   Åsberg, Anders ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Acute rejection; Ciclosporin A; Endomyocardial biopsies; Heart transplantation; T lymphocytes

Indexed keywords

CYCLOSPORIN A; DRUG METABOLITE; MULTIDRUG RESISTANCE PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIAC GRAFT REJECTION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG MONITORING; FEMALE; GENETIC POLYMORPHISM; HEART GRAFT; HEART MUSCLE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FUNCTION; LYMPHOCYTE; MALE; MASS SPECTROMETRY; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; T LYMPHOCYTE;

EID: 84929331422     PISSN: None     EISSN: 20471440     Source Type: Journal    
DOI: 10.1186/2047-1440-2-5     Document Type: Article

References (38)

1. Christians U, Sewing KF. Cyclosporine metabolism in transplant patients. Pharmacol Ther 1993, 57:291-345. 10.1016/0163-7258(93)90059-M, 8361996.
2. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human p-glycoprotein transports cyclosporine A and FK506. J Biol Chem 1993, 268:6077-6080.
3. Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance p-glycoprotein in human peripheral-blood lymphocytes. Blood 1992, 80:2735-2739.
4. Lown KS, Mayo RR, Leichtman AB, Hsiao HL, Turgeon DK, SchmiedlinRen P, Brown MB, Guo WS, Rossi SJ, Benet LZ, Watkins PB. Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine. Clin Pharmacol Ther 1997, 62:248-260. 10.1016/S0009-9236(97)90027-8, 9333100.
5. Crettol S, Venetz JP, Fontana M, Aubert JD, Ansermot N, Fathi M, Pascual M, Eap CB. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients. Pharmacogenet Genomics 2008, 18:307-315. 10.1097/FPC.0b013e3282f7046f, 18334915.
6. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991, 66:807-815. 10.1016/0092-8674(91)90124-H, 1715244.
7. Falck P, Asberg A, Guldseth H, Bremer S, Akhlaghi F, Reubsaet JLE, Pfeffer P, Hartmann A, Midtvedt K. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation 2008, 85:179-184. 10.1097/TP.0b013e31815feede, 18212621.
8. Barbari AG, Masri M, Stephan AG, El Ghoul B, Rizk S, Mourad N, Kamel GS, Kilani HE, Karam AS. Cyclosporine lymphocyte maximum level monitoring in de novo kidney transplant patients: a prospective study. Exp Clin Transplant 2006, 4:400-405.
9. Barbari A, Masri MA, Stephan A, Mokhbat J, Kilani H, Rizk S, Kamel G, Joubran N. Cyclosporine lymphocyte versus whole blood pharmacokinetic monitoring: correlation with histological findings. Transplant Proc 2001, 33:2782-2785. 10.1016/S0041-1345(01)02190-X, 11498159.
10. Gustafsson F, Barth D, Delgado DH, Nsouli M, Sheedy J, Ross HJ. The impact of everolimus versus mycophenolate on blood and lymphocyte cyclosporine exposure in heart-transplant recipients. Eur J Clin Pharmacol 2009, 65:659-665. 10.1007/s00228-009-0663-2, 19458944.
11. Winters GL, Marboe CC, Billingham ME. The international society for heart and lung transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant 1998, 17:754-760.
12. Stewart S, Winters GL, Fishbein MC, Tazelaar HD, Kobashigawa J, Abrams J, Andersen CB, Angelini A, Berry GJ, Burke MM, Demetris AJ, Hammond E, Itescu S, Marboe CC, McManus B, Reed EF, Reinsmoen NL, Rodriguez ER, Rose AG, Rose M, Suciu-Focia N, Zeevi A, Billingham ME. Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant 2005, 24:1710-1720. 10.1016/j.healun.2005.03.019, 16297770.
13. Berhanu D, Mortari F, De Rosa SC, Roederer M. Optimized lymphocyte isolation methods for analysis of chemokine receptor expression. J Immunol Methods 2003, 279:199-207. 10.1016/S0022-1759(03)00186-8, 12969561.
14. Goldberg H, Ling V, Wong PY, Skorecki K. Reduced cyclosporin accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 1988, 152:552-558. 10.1016/S0006-291X(88)80073-1, 2896500.
15. Collins DP. Cytokine and cytokine receptor expression as a biological indicator of immune activation: important considerations in the development of in vitro model systems. J Immunol Methods 2000, 243:125-145. 10.1016/S0022-1759(00)00218-0, 10986411.
16. Falck P, Guldseth H, Asberg A, Midtvedt K, Reubsaet JLE. Determination of ciclosporin A and its six main metabolites in isolated T-lymphocytes and whole blood using liquid chromatography-tandem mass spectrometry. J Chromatogr B 2007, 852:345-352.
17. Cascorbi I, Gerloff T, Johne A, Meisel C, Hoffmeyer S, Schwab M, Schaeffeler E, Eichelbaum M, Brinkmann U, Roots I. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects. Clin Pharmacol Ther 2001, 69:169-174. 10.1067/mcp.2001.114164, 11240981.
18. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Group* ftMoDiRDS A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999, 130:461-470. 10.7326/0003-4819-130-6-199903160-00002, 10075613, Group* ftMoDiRDS.
19. Buron F, Hadj-Aissa A, Dubourg L, Morelon E, Steghens JP, Ducher M, Fauvel JP. Estimating glomerular filtration rate in kidney transplant recipients: performance over time of four creatinine-based formulas. Transplantation 2011, 92:1005-1011.
20. Delgado DH, Rao V, Hamel J, Miriuka S, Cusimano RJ, Ross HJ. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes. J Heart Lung Transplant 2005, 24:1343-1346. 10.1016/j.healun.2004.08.002, 16143255.
21. Davies RA, Veinot JP, Williams K, Haddad H, Baker A, Donaldson J, Pugliese C, Struthers C, Masters RG, Hendry PJ, Mesana T. Assessment of cyclosporine pharmacokinetic parameters to facilitate conversion from C0 to C2 monitoring in heart transplant recipients. Transplant Proc 2007, 39:3334-3339. 10.1016/j.transproceed.2007.08.109, 18089382.
22. Masri MA, Barbari A, Stephan A, Rizk S, Kilany H, Kamel G. Measurement of lymphocyte cyclosporine levels in transplant patients. Transplant Proc 1998, 30:3561-3562. 10.1016/S0041-1345(98)01437-7, 9838559.
23. Ansermot N, Rebsamen M, Chabert J, Fathi M, Gex-Fabry M, Daali Y, Besson M, Rossier M, Rudaz S, Hochstrasser D, Dayer P, Desmeules J. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers. Drug Metab Lett 2008, 2:76-82. 10.2174/187231208784040951, 19356075.
24. Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study. Transpl Int 2012, 25:41-47. 10.1111/j.1432-2277.2011.01365.x, 21981711.
25. Capron A, Lerut J, Verbaandert C, Mathys J, Ciccarelli O, Vanbinst R, Roggen F, De Reyck C, Lemaire J, Wallemacq PE. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in liver biopsies after hepatic transplantation: correlation with histopathologic staging of rejection. Ther Drug Monit 2007, 29:340-348. 10.1097/FTD.0b013e31805c73f1, 17529892.
26. Burckart GJ, Liu XMI. Pharmacogenetics in transplant patients - can it predict pharmacokine tics and pharmacodynamics?. Ther Drug Monit 2006, 28:23-30. 10.1097/01.ftd.0000194502.85763.bc, 16418689.
27. Kemnitz J, Uysal A, Haverich A, Heublein B, Cohnert TR, Stangel W, Georgii A. Multidrug resistance in heart transplant patients - a preliminary communication on a possible mechanism of therapy-resistant rejection. J Heart Lung Transplant 1991, 10:201-210.
28. Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Therapeut 1996, 34:515-519.
29. Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996, 50:1089-1100. 10.1038/ki.1996.415, 8887265.
30. Herlitz H, Lindelow B. Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000, 15:311-314. 10.1093/ndt/15.3.311, 10692514.
31. Falck P, Fiane AE, Geiran OR, Åsberg A. Individual differences in cyclosporine A pharmacokinetics and its association with acute renal function following heart transplantation. Open Transplant J 2009, 3:9-13.
32. Rosano TG, Pell MA, Freed BM, Dybas MT, Lempert N. Cyclosporine and metabolites in blood from renal allograft recipients with nephrotoxicity, rejection, or good renal function - comparative high-performance liquid chromatography and monoclonal radioimmunoassay studies. Transplant Proc 1988, 20:330-338.
33. Kohlhaw K, Wonigeit K, Schafer O, Ringe B, Bunzendahl H, Pichlmayr R. Association of very high blood levels of cyclosporine metabolites with clinical complications after liver transplantation. Transplant Proc 1989, 21:2232-2233.
34. Wonigeit K, Kohlhaw K, Winkler M, Schaefer O, Pichlmayr R. Cyclosporine monitoring in liver allograft recipients- 2 distinct patterns of blood level derangement associated with nephrotoxicity. Transplan Proc 1990, 22:1305-1311.
35. Christians U, Kohlhaw K, Budniak J, Bleck JS, Schottmann R, Schlitt HJ, Almeida VMF, Deters M, Wonigeit K, Pichlmayr R, Sewing KF. Ciclosporin metabolite pattern in blood and urine of liver graft recipients. 1. association of ciclosporin metabolites with nephrotoxicity. Eur J Clin Pharmacol 1991, 41:285-290. 10.1007/BF00314953, 1804640.
36. Dai Y, Iwanaga K, Lin YS, Hebert MF, Davis CL, Huang WL, Kharasch ED, Thummel KE. In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol 2004, 68:1889-1902. 10.1016/j.bcp.2004.07.012, 15450954.
37. Zheng S, Tasnif Y, Hebert MF, Davis CL, Shitara Y, Calamia JC, Lin YS, Shen DD, Thummel KE. Measurement and compartmental modeling of the effect of CYP3A5 gene variation on systemic and intrarenal tacrolimus disposition. Clin Pharmacol Ther 2012, 92:737-745. 10.1038/clpt.2012.175, 23073208.
38. Kempkes-Koch M, Fobker M, Erren M, August C, Gerhardt U, Suwelack B, Hohage H. Cyclosporine A metabolite AM19 as a potential biomarker in urine for CSA nephropathy. Transplant Proc 2001, 33:2167-2169. 10.1016/S0041-1345(01)01929-7, 11377489.